Concord Biotech Ltd. - Research Center
543960 CONCORDBIO Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | ||||
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 10.46 | 10.46 | |||
| Share application money | - | - | |||
| Preference share capital | - | - | |||
| Reserves & surplus | 1,514.79 | 1,281.52 | |||
| Loan funds | |||||
| Secured loans | 6.23 | 31.24 | |||
| Unsecured loans | - | - | |||
| Total | 1,531.48 | 1,323.22 | |||
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 813.77 | 781.39 | |||
| Less : revaluation reserve | - | - | |||
| Less : accumulated depreciation | 238.46 | 188.41 | |||
| Net block | 575.32 | 592.98 | |||
| Capital work-in-progress | 211.48 | 172.70 | |||
| Investments | 244.37 | 137.72 | |||
| Net current assets | |||||
| Current assets, loans & advances | 668.15 | 611.25 | |||
| Less : current liabilities & provisions | 167.83 | 191.43 | |||
| Total net current assets | 500.32 | 419.82 | |||
| Miscellaneous expenses not written | - | - | |||
| Total | 1,531.48 | 1,323.22 | |||
| Notes: | |||||
| Book value of unquoted investments | 0.67 | 0.67 | |||
| Market value of quoted investments | 243.70 | 137.05 | |||
| Contingent liabilities | 26.75 | 26.59 | |||
| Number of equity sharesoutstanding (Lacs) | 1046.16 | 1046.16 | |||
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis